Psilocybin mushrooms, akin to LSD in their role as a serotonin 5-HT2A receptor agonist, are a traditional form of psychedelic substance. Presently, they are a subject of research in psilocybin-facilitated therapy for mental health issues, such as emotional turmoil related to major depression, anxiety, cluster headaches, and migraines.
To understand how shrooms assist in these conditions, it’s essential to delve into how they are metabolized in the body. This knowledge empowers researchers and users to discern how the active compound generates psychological and therapeutic effects. This article offers a basic explanation of psilocybin’s pharmacology and pharmacokinetics.
[toc]
Key Takeaways:
- Half of the psychedelic fungi consumed orally is absorbed and distributed throughout the body.
- The fungi compound undergoes dephosphorylation via the enzyme alkaline phosphatase, primarily in the liver.
- About 3.4% of the compound is excreted in its original form within 24 hours, with the majority being expelled as a stable metabolite.
What is Pharmacokinetics?
Pharmacokinetics (PK) is the analysis of how the body metabolizes substances, like drugs, once they’ve been introduced into the system. Although related, it’s different from pharmacodynamics, which studies how a compound interacts with the body. PK explores four main aspects: absorption, distribution, metabolism, and excretion (ADME).
Grasping these processes allows healthcare practitioners to prescribe the most efficacious medications with the least risk. It also empowers them to personalize treatments based on each patient’s unique physiological and lifestyle factors.
How does Pharmacokinetics Relate to Psilocybin?
Psilocybin and psilocin, the predominant active compounds in certain types of magic mushrooms, have intrigued both researchers and users. Pharmacokinetics studies how the body metabolizes mushrooms containing psilocybin, aiding in understanding their potential effects, medicinal or recreational.
These compounds are referred to by various names, such as “magic,” “psychedelic,” “medicinal,” or “sacred.” The fungi containing these compounds are consumed, with The Different mushroom species, their origin, size, growing and drying conditions, and age can significantly alter the concentrations they contain.
While these mushrooms are naturally found in the wild, scientists have also succeeded in creating them synthetically in laboratories. Both the natural and lab-made variants exhibit low toxicity, though they may cause minor side effects such as nausea or vomiting.
Despite these physical side effects, the compounds within these mushrooms have demonstrated potential therapeutic benefits due to their safe profile and lack of addictive qualities. These benefits have prompted researchers to investigate their use in psychotherapy, particularly in treating anxiety and depression.
The 4 Stages of Pharmacokinetics
Psilocybin, the compound present in these mushrooms, is inactive in its raw form and acts as a prodrug, converting into its active form, psilocin. Enzymes such as alkaline phosphatase facilitate this transformation, enabling psilocin to be absorbed and circulated in the body, reaching various tissues. However, after oral administration, psilocybin cannot be detected in the circulatory system, feces, or urine.
Absorption
Absorption refers to the process by which the compound enters the bloodstream from its administration site. It affects the rate and effectiveness of the compound reaching its target, such as the plasma. Oral intake is the most common administration method. Although inhalation has been tried, it is not as effective as oral consumption.
The absorption process also includes the release of the compound from the dosage form during oral consumption. Factors like delays in the throat or esophagus can affect this, potentially slowing down the effects or causing irritation. Once the compound arrives at the stomach, the acidic environment may start to degrade it before it enters the bloodstream.
Studies conducted on animals suggest that only about 50% of orally administered psychedelics get absorbed and distributed throughout the body.
Factors Influencing the Absorption Process
Various factors can affect the absorption process, leading to differences in the onset, intensity, and duration of the effects:
- Stomach Contents: Eating before taking the compound can delay the process as it reduces the rate of onset. Conversely, an empty stomach allows for quicker absorption.
- Body Fat: Compounds can accumulate in fatty tissues, which may potentially prolong their effects.
- Age: With age, metabolic rates and body composition can change.
- Zero-Order Kinetics: The substance is removed at a steady rate, regardless of its concentration.
- First-Order Kinetics: The elimination rate is directly proportional to the concentration of the drug.
The term “distribution” pertains to the dissemination of psilocin throughout the body once it has entered the bloodstream. Psilocin, being fat-soluble, has the ability to surpass the blood-brain barrier and access the central nervous system.
system.The dispersion process is influenced by factors such as the size, polarity, and protein-binding capacity of the substance, as well as individual physiology aspects, including hydration status and body composition.
The goal is to establish an effective concentration in the target area. For efficacy, the substance needs to reach the specific location, as dictated by the volume of distribution, and remain unbound to proteins, which allows it to actively engage with its receptor.
What Factors Impact the Distribution Process?
Several elements can influence the distribution process:
Typically, the effects start to manifest between 20-40 minutes after ingestion, peaking around 80-100 minutes. The effects of magic mushrooms generally last between 4-6 hours.
How Does Distribution to the Brain Happen?
An early experimental study on two species indicated that the binding affinity sequence is 5HT2A > 5HT1A > 5HT2B [23]. It also binds to dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
It acts as a partial agonist at the 5HT2A receptor, with an efficacy of around 40%. The psychedelic effects can be linked to its partial agonist activity at 5HT1A autoreceptors.
The mood-lifting and psychotomimetic experiences might be attributed to the perceived relationship between increased dopamine levels and sensations of depersonalization and happiness. Hallucinogens work by modifying neurochemistry and receptor activity. They enhance 5HT2A agonist activity by boosting BDNF synthesis in the hippocampus, promoting neurogenesis and reducing behaviors related to conditioned fear.
Excretion
Excretion refers to the process where the The body discharges a compound mainly through the kidneys, but also via the lungs, skin, and gastrointestinal tract. In the context of the kidneys, a naturally occurring psychedelic drug gets filtered in the glomerulus or secreted in the tubules, and a certain degree of reabsorption renders the process more complex.
The primary compound has a half-life of around 160 minutes, and psilocin’s half-life is approximately 50 minutes. Animal research indicates that this compound is mainly excreted in the urine, accounting for about 65% within 8 hours. After consumption, smaller amounts of the substance can still be detected in bile and feces.
In the human body, around 3.4% of the substance is excreted in its original form within 24 hours, while most is removed as psilocin-O-glucuronide, a more stable metabolite. This stability allows the compound to be identifiable in urine samples for a longer time.
The substance is primarily expelled through two methods:
Most psychedelic drugs follow the first-order kinetics method, reaching stable concentrations after four to five half-lives. Complete removal also occurs after four to five half-lives.
Discover Our Range of Hallucinogenic Mushrooms
The metabolic process can differ among various types of fungi. By buying from reliable online suppliers such as Strongest Shroom Strain Canada, you can steer clear of inadvertently ingesting toxic mushrooms. Some varieties, like Agaric mushrooms, may induce intense and undesirable effects. Hence, it’s vital to procure magic mushrooms from trusted dispensaries instead of unreliable street vendors or wild foraging.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Exceptionally high; 3.8% tryptamine content | Moderate to high potency | High potency | |
| Visual Characteristics | Looks like a blob or | Resembles a cauliflower or brain structure | Displays a traditional cubensis appearance and is moderately sized | Characterized by thick white stems, golden caramel caps, and obvious blue bruising |
| Effects | Known as the most potent, it yields intense effects | Induces a strong mental high with a delayed onset, accompanied by vivid visuals | Produces vivid visuals and a state of euphoria |
Educate Yourself on Psilocybin Mushroom Usage Online
For medical professionals, researchers, and users, it’s crucial to comprehend the pharmacokinetics of shrooms. With this understanding, you can make well-informed decisions regarding dosage and timing, thus mitigating potential risks.
Discover your perfect psychedelic journey at Strongest Shroom Strain Canada. Whether you’re after a soothing trip or a deeper exploration, our extensive product selection caters to your unique needs. Enjoy premium, safe, and quality-assured shrooms, eliminating worries about dubious sources or poisonous mushrooms.
Experience the best magic mushrooms Canada has to offer and amplify your psychedelic adventure to unparalleled heights.
Frequently Asked Questions
Do shrooms interact with other medicines?
Our products may interact with certain medicines, especially those affecting serotonin levels, such as SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) usually lessen the effects, unlike non-serotonergic antidepressants. This reduced effect can last up to three months after stopping the antidepressant use.
Do all psychedelics operate the same way as psilocybin?
No, each psychedelic substance has a unique structure that requires different metabolic processes to become active, and they attach to different receptors in the body. The mode of administration also affects each psychedelic’s absorption. While the basic principles of absorption, metabolism, and distribution are the same, the specific pathways and effects vary for each substance.
Does the form of the shroom affect its pharmacokinetics?
Yes, the form of the shroom (be it fresh, powdered, or dried mushrooms) can influence the absorption rate. For example, powdered forms may be absorbed faster than whole dried ones due to faster dissolution.
Further Reading:
